Microbial-derived immunostimulatory small molecule augments anti-PD-1 therapy in lung cancer
Year: 2025
Type: article
Abstract: Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.
Source: Cell Reports Medicine
Authors: Rachel C. Newsome, Huijia Liu, Bright Agbodzi, Raad Z. Gharaibeh, Liang Zhou, Christian Jobin
Institutions: University of Florida Health, University of Florida
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,620
Funders: U.S. Department of Defense, Foundation for the National Institutes of Health, Yale University, University of Florida, National Institutes of Health, Office of the Director, University of Florida Health, International Centre for Bamboo and Rattan, NIH Office of the Director, National Cancer Institute, College of Medicine, University of Florida, Cancer Center, University of Florida Health, Cancer Center, University of Florida Health
Awards: G1863192410, Together: Transforming and Translating Discovery to Improve Health, G2294844187, Acquisition of a Q Exactive HF Hybrid Quadrupole-Orbitrap, G3715736040, G4591074549, G4897168572, G5555762652, Olympus VS200 Brightfield/Fluorescence whole slide scanner with slide tower, G6243167882, J. NRSA Training Core, G6665007911, Acquisition of timsTOF Pro for Complex Lipidomic Analyses, Team-based Interdisciplinary Cancer Research Training Program, University of Florida Health Cancer Center Support Grant, Role of bacterial-derived small molecules in immunotherapy
OpenAlex ID: W7116041999